INVENTIVA: Combined General Meeting of May 19, 2022 - Availa

Daix (France), Long Island City (New York, United States), April 28, 2022 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small

Related Keywords

New York , United States , Daix , Bourgogne , France , Russia , Le Jura , France General , Brunswick , Niedersachsen , Germany , Ukraine , French , Yannick Tetzlaff , Aude Lepreux , Patricial Bank , Brunswick Group , Exchange Commission On , Nasdaq , Long Island City , Euronext Paris , Combined General Meeting , Oceania Le Jura , Exchange Commission , French Commercial Code , Rue De Dijon , Combined General , General Meeting , Private Securities Litigation Reform Act , Universal Registration Document , Des March , Annual Report , Roquet Montegon , Inventiva , Combined , Eneral , Meeting , 022 , Availability , Preparatory , Documents ,